<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-142043" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Kell Blood Group System</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maheshwari</surname>
            <given-names>Ashish</given-names>
          </name>
          <aff>Institute of Liver and Biliary Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maheshwari</surname>
            <given-names>Apoorva</given-names>
          </name>
          <aff>ILBS HOSPITAL NEW DELHI INDIA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashish Maheshwari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Apoorva Maheshwari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-142043.s1" sec-type="Introduction">
        <title>Introduction</title>
        <p content-type="pubmed-excerpt">The Kell blood group system is vast, with 38 blood group antigens.<xref ref-type="bibr" rid="article-142043.r1">[1]</xref> The Kell system is notorious for its immunogenicity, which is third after ABO and Rhesus D.<xref ref-type="bibr" rid="article-142043.r2">[2]</xref>&#x000a0;This system is involved in severe forms of hemolytic disease of the fetus and newborn and hemolytic transfusion reactions. Further, this blood group system is associated with chronic granulomatous diseases and a multisystem syndrome involving neurological, cardiovascular, and hematologic symptoms called McLeod syndrome.<xref ref-type="bibr" rid="article-142043.r3">[3]</xref>&#x000a0;The symbol of the Kell blood group system as per "International Society of Blood Transfusion" (ISBT) is KEL; ISBT number: 006.</p>
        <p><bold>History: </bold>The Kell blood group system was described in 1946 and named after Mrs Kelleher, whose newborn child died of hemolytic disease of fetus and newborn (HDFN) due to an antibody against his red blood cells (RBCs). This antibody also reacted with her daughter's and husband's RBCs and was named anti-K. Later, its antithetical antigen k was discovered in 1949, and the null phenotype (K0) in 1957.<xref ref-type="bibr" rid="article-142043.r4">[4]</xref></p>
        <p><bold>Genetics:&#x000a0;</bold>The <italic toggle="yes">KEL&#x000a0;</italic>gene encodes the Kell antigens and&#x000a0;is located at chromosome 7q34, comprising 20 exons spanning 21.25 kb of genomic DNA. This gene is also known as Kell metallo-endopeptidase, ECE3, or <italic toggle="yes">CD238</italic>. Single nucleotide polymorphisms are responsible for multiple Kell antigens. Another important XK gene&#x000a0;required for the expression of Kell antigen is present on the short arm of chromosome X (Xp21.1) and is responsible for forming the Kx antigen.<xref ref-type="bibr" rid="article-142043.r5">[5]</xref></p>
        <p><bold>Structure of Kell glycoprotein:&#x000a0;</bold>The <italic toggle="yes">KEL</italic> gene encodes the polymorphic Kell and para-Kell glycoproteins, structurally single-pass RBC membrane proteins, or type II glycoproteins. The N terminal is intracytoplasmic, and the C terminal is multi-folded, bound by disulfide bonds, and extracytoplasmic. They constitute around 732 amino acids; mutations in these lead to the formation of a multitude of Kell antigens.<xref ref-type="bibr" rid="article-142043.r6">[6]</xref>&#x000a0;The&#x000a0;Kell glycoprotein is covalently linked to the Kx protein via a single disulfide bond. This Kx antigen protein traverses the RBC membrane 10 times. The absence of Kx protein leads to McLeod syndrome.<xref ref-type="bibr" rid="article-142043.r7">[7]</xref>&#x000a0;The Kell glycoproteins have been found to have a similar sequence as the neprilysin (M13) family of zinc endopeptidases and, hence, act like proteolytic enzymes. They share a pentameric sequence HEXXH, which is needed to add zinc and proteolytic activity. Kell preferentially cleaves big endothelin-3, converting it to the bioactive peptide endothelin-3. This potent vasoconstrictor peptide leads to vascular endothelial growth factor formation.<xref ref-type="bibr" rid="article-142043.r8">[8]</xref><xref ref-type="bibr" rid="article-142043.r9">[9]</xref></p>
        <p><bold>Antigens:&#x000a0;</bold>The Kell system is highly polymorphic, consisting of 38 different blood group antigens.<xref ref-type="bibr" rid="article-142043.r10">[10]</xref><xref ref-type="bibr" rid="article-142043.r11">[11]</xref>&#x000a0;The Kell antigens are found on erythroid cells and progenitor myeloid cells and are also present in skeletal muscles and testes.<xref ref-type="bibr" rid="article-142043.r12">[12]</xref><xref ref-type="bibr" rid="article-142043.r13">[13]</xref></p>
        <p>
<bold>Common Kell Antigens</bold>
</p>
        <p>
<bold>K antigen:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL1</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.001</p>
          </list-item>
          <list-item>
            <p>Low prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: k (KEL 2)</p>
          </list-item>
          <list-item>
            <p>Cord RBCs: Expressed</p>
          </list-item>
        </list>
        <p>The K antigen is detected on fetal RBCs as early as&#x000a0;the tenth gestational week and is well-developed at birth. The KEL1 antigen is strongly immunogenic after the Rh blood group system. Study results have reported that every 1 out of 10 Kell antigen-negative individuals transfused with Kell antigen-positive donor red cells can develop anti-K antibodies after transfusion.</p>
        <p>The K antigen is not denatured by the enzymes ficin and papain but is destroyed by combined trypsin and chymotrypsin. Additionally, dithiothreitol (DTT), 2-mercaptoethanol, 2-aminoethylisothiouronium bromide, and ZZAP (mixture of a sulfhydryl reagent [dithiothreitol] and a proteolytic enzyme [papain or ficin]) can also destroy the Kell antigen. DTT, a reducing agent, interferes with the disulfide bonds between amino acids essential for the structural integrity of specific proteins and maintaining the pentameric structure of immunoglobulin (Ig) M molecules. Treating RBCs with DTT can denature other blood group antigens, including Kell, Lutheran, Yt, John Milton Hagen (JMH), Landsteiner-Wiener (LW), Cromer, Indian, Dombrock, and Knops systems&#x02014;potentially impacting the recognition of these antigens by their specific antibodies.</p>
        <p>
<bold>k (Cellano) antigen:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL2</p>
          </list-item>
          <list-item>
            <p>Formerly termed as Cellano</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.002</p>
          </list-item>
          <list-item>
            <p>High prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: K (KEL1)</p>
          </list-item>
          <list-item>
            <p>Cord RBCs: Expressed</p>
          </list-item>
          <list-item>
            <p>Detected as early as seven weeks of gestation.</p>
          </list-item>
          <list-item>
            <p>Resistance and sensitivity to enzymes and chemicals are the same as those of KEL1</p>
          </list-item>
        </list>
        <p>
<bold>Kp<sup>a </sup>antigen: </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL3</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.003</p>
          </list-item>
          <list-item>
            <p>Low prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: Kp<sup>b</sup> (KEL4) Kp<sup>c </sup>(KEL21)</p>
          </list-item>
          <list-item>
            <p>Cord RBCs: Expressed</p>
          </list-item>
          <list-item>
            <p>Resistant to enzymes (ficin, papain, chymotrypsin)</p>
          </list-item>
        </list>
        <p>
<bold>Kp<sup>b </sup>antigen: </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL4</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.004</p>
          </list-item>
          <list-item>
            <p>High prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: Kp<sup>a</sup> (KEL3) Kp<sup>c </sup>(KEL21)</p>
          </list-item>
          <list-item>
            <p>Cord RBC's: Expressed</p>
          </list-item>
          <list-item>
            <p>Resistant to enzymes (ficin, papain, chymotrypsin)</p>
          </list-item>
        </list>
        <p>
<bold>Js<sup>a </sup>antigen:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL6</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.006</p>
          </list-item>
          <list-item>
            <p>Low prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: Js<sup>b</sup> (KEL7)</p>
          </list-item>
          <list-item>
            <p>Cord RBCs: Expressed</p>
          </list-item>
          <list-item>
            <p>Resistant to enzymes (ficin, papain, chymotrypsin)</p>
          </list-item>
        </list>
        <p>
<bold>Js<sup>b </sup>antigen:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>ISBT symbol: KEL7</p>
          </list-item>
          <list-item>
            <p>ISBT number: 006.007</p>
          </list-item>
          <list-item>
            <p>High prevalence antigen</p>
          </list-item>
          <list-item>
            <p>Antithetical antigen: Js<sup>a</sup> (KEL6)</p>
          </list-item>
          <list-item>
            <p>Cord RBC: Expressed</p>
          </list-item>
          <list-item>
            <p>Resistant to enzymes (ficin, papain, chymotrypsin)</p>
          </list-item>
        </list>
        <p>
<bold>Other rare Kell antigens</bold>
</p>
        <p>These are further divided as high and low-prevalence antigens:</p>
        <p><bold>High prevalence&#x000a0;antigens:&#x000a0;</bold>Ku (KEL5), KEL11, KEL12, KEL13, KEL14, KEL16, KEL18, KEL19, Km (KEL20), KEL22, TOU (KEL26), RAZ (KEL27), KALT (KEL29), KTIM (KEL30), KUCI (KEL32), KANT (KEL33), KASH (KEL34), KELP (KEL35), KETI (KEL36), KHUL(KEL37), KYOR(KEL38), KEL40</p>
        <p><bold>Low prevalence antigens:&#x000a0;</bold>Ula&#x000a0;(KEL10), Wka&#x000a0;(KEL17), KEL21, KEL23, KEL24, VLAN (KEL25), VONG (KEL28), KYO (KEL31), KEAL (KEL39), KEL41</p>
        <p>
<bold>Antibodies of the Kell Blood Group System</bold>
</p>
        <p>Anti-K antibodies, commonly IgG antibodies, do not bind complement and mostly react at 37 &#x000b0;C&#x000a0;with the anti-human globulin (AHG) phase. Anti-K antibodies can also react at room temperature in the saline phase if they are IgM-type; they are usually formed in response to exposure following pregnancy or transfusion, but some examples of naturally occurring anti-K can also be seen. These IgM antibodies have been found in patients with <italic toggle="yes">Escherichia coli</italic> infections, which disappear after recovery.<xref ref-type="bibr" rid="article-142043.r14">[14]</xref></p>
        <p>Anti-K antibodies may show depressed reactivity with some low&#x02013;ionic-strength solution reagents, so an AHG phase is required to detect these antibodies.<xref ref-type="bibr" rid="article-142043.r15">[15]</xref>&#x000a0;Anti-K has been implicated in severe hemolytic transfusion reactions and HDFN. If a patient develops antibodies to high-prevalence Kell antigens like k, it is challenging to find compatible units due to the low percentage of antigen-negative donors; antibody formation is rare due to its high prevalence.</p>
        <p>Identifying antibodies against low-prevalence antigens is difficult as their corresponding antigens are not included in antibody identification panels, which can rarely present as unexpected HDFN or transfusion reactions (see <bold>Table.</bold>&#x000a0;Kell Blood Group Frequencies in Different Populations by Percentage). Anti-K will react well with K+k+ and K+k&#x02212; red cells in antibody panels, showing no dosage phenomena. A rare case report of anti-Js<sup>b</sup> was found in the Nigerian population, where this antibody was associated with decreased red cell survival.<xref ref-type="bibr" rid="article-142043.r16">[16]</xref>&#x000a0;</p>
        <table-wrap id="article-142043.table0" position="float" orientation="portrait">
          <caption>
            <title>Table.&#x000a0;Kell Blood Group Frequencies in Different Populations by Percentage</title>
          </caption>
          <table style="margin-left: auto; margin-right: auto; height: 178px;" border="all">
            <tbody>
              <tr>
                <td style="width: 94.875px;" rowspan="1" colspan="1">
<p><bold>Phenotype</bold></p>
</td>
                <td style="width: 90.1736px;" rowspan="1" colspan="1">
<p><bold>Caucasian</bold></p>
</td>
                <td style="width: 53.8125px;" rowspan="1" colspan="1">
<p><bold>Black</bold></p>
</td>
                <td style="width: 57.3125px;" rowspan="1" colspan="1">
<p><bold>Arabic</bold></p>
</td>
                <td style="width: 66.6042px;" rowspan="1" colspan="1">
<p><bold>Indian</bold></p>
</td>
                <td style="width: 70.4375px;" rowspan="1" colspan="1">
<p><bold>Chinese</bold></p>
</td>
                <td style="width: 83.125px;" rowspan="1" colspan="1">
<p><bold>Japanese</bold></p>
</td>
                <td style="width: 78.6597px;" rowspan="1" colspan="1">
<p><bold>Brazilian</bold></p>
</td>
              </tr>
              <tr>
                <td style="width: 94.875px;" rowspan="1" colspan="1">
<p><bold>K+k-</bold></p>
</td>
                <td style="width: 90.1736px;" rowspan="1" colspan="1">
<p>9%</p>
</td>
                <td style="width: 53.8125px;" rowspan="1" colspan="1">
<p>2%</p>
</td>
                <td style="width: 57.3125px;" rowspan="1" colspan="1">
<p>20%</p>
</td>
                <td style="width: 66.6042px;" rowspan="1" colspan="1">
<p>4%</p>
</td>
                <td style="width: 70.4375px;" rowspan="1" colspan="1">
<p>&#x0003c;0.1%</p>
</td>
                <td style="width: 83.125px;" rowspan="1" colspan="1">
<p>&#x0003c;0.1%</p>
</td>
                <td style="width: 78.6597px;" rowspan="1" colspan="1">
<p>5%</p>
</td>
              </tr>
              <tr>
                <td style="width: 94.875px;" rowspan="1" colspan="1">
<p><bold>K-k+</bold></p>
</td>
                <td style="width: 90.1736px;" rowspan="1" colspan="1">
<p>99.8%</p>
</td>
                <td style="width: 53.8125px;" rowspan="1" colspan="1">
<p>99.9%</p>
</td>
                <td style="width: 57.3125px;" rowspan="1" colspan="1">
<p>99.1%</p>
</td>
                <td style="width: 66.6042px;" rowspan="1" colspan="1">
<p>&#x0003e;99.9%</p>
</td>
                <td style="width: 70.4375px;" rowspan="1" colspan="1">
<p>&#x0003e;99.9%</p>
</td>
                <td style="width: 83.125px;" rowspan="1" colspan="1">
<p>&#x0003e;99.9%</p>
</td>
                <td style="width: 78.6597px;" rowspan="1" colspan="1">
<p>99.9%&#x000a0;<xref ref-type="bibr" rid="article-142043.r17">[17]</xref><xref ref-type="bibr" rid="article-142043.r18">[18]</xref><xref ref-type="bibr" rid="article-142043.r19">[19]</xref><xref ref-type="bibr" rid="article-142043.r20">[20]</xref></p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Uncommon Kell Phenotypes</bold>
</p>
        <p><bold>K0 phenotype and anti-Ku antibody: </bold>K0 or Kell null phenotype was identified by Chown et al in 1957, and it lacks all Kell antigens on the RBCs. The Kell null phenotype shows a prevalence of 0.001% except in populations of Finland and Japan.<xref ref-type="bibr" rid="article-142043.r21">[21]</xref><xref ref-type="bibr" rid="article-142043.r22">[22]</xref>&#x000a0;These individuals show the inheritance of 2 recessive K0 genes in homozygotes (K0 K0). The absent antigens do not cause any functional abnormality in&#x000a0;these RBCs.<xref ref-type="bibr" rid="article-142043.r5">[5]</xref>&#x000a0;The alloantibody in K0 individuals post-transfusion has been called anti-Ku (anti-KEL5), which is clinically significant.<xref ref-type="bibr" rid="article-142043.r23">[23]</xref>&#x000a0;These recipients should only be transfused with the K0&#x000a0;red cell type. One case report shows that anti-Ku specificity and anti-H were also identified in co-trimoxazole (trimethoprim and sulfamethoxazole) dependent antibodies.<xref ref-type="bibr" rid="article-142043.r24">[24]</xref>&#x000a0;If there is a diminished presence of Kell antigens in place of complete absence, the phenotype is called Kmod. This is due to multiple missense mutations in the glycoprotein. Both K0 and Kmod&#x000a0;show&#x000a0;increased Kx protein. Kmod individuals may also form anti-Ku-type antibodies, but neither are similar.<xref ref-type="bibr" rid="article-142043.r25">[25]</xref>&#x000a0;</p>
        <p><bold>McLeod phenotype: </bold>This rare phenotype occurs due to the absence of the Kx protein.&#x000a0;Kell glycoprotein is covalently linked to Kx protein by a single disulfide bond, and hence, in its absence, it lacks a high prevalence Kell antigen and has depression of the rest. Individuals with this phenotype develop a neuromuscular syndrome, McLeod syndrome.<xref ref-type="bibr" rid="article-142043.r26">[26]</xref>&#x000a0;This condition is an X-linked recessive disorder where females are carriers and males are affected. At the molecular level, it can be due to a hemizygous XK pathogenic variant (90%) or a hemizygous deletion of Xp21.1 (10%).<xref ref-type="bibr" rid="article-142043.r27">[27]</xref>&#x000a0;The Kell blood group system antigens are expressed weakly in individuals with McLeod syndrome, except for the Km antigen (KEL20), which is absent. The <italic toggle="yes">XK</italic> gene encodes a protein that helps properly express antigens of the Kell blood group system on the RBC surface. When this gene is mutated, it leads to the functional ineffectiveness of the Kell antigens.<xref ref-type="bibr" rid="article-142043.r28">[28]</xref></p>
        <p><bold>Depressed Kell antigen (Cellano) in Gerbich-negative phenotypes: </bold>Both Muller and Debien reported reduced expression of 'k' antigens in RBCs of Gerbich group-negative phenotype (Ge:-2,-3) in&#x000a0;individuals using monoclonal anti-k. This may be due to conformational changes in epitopes of the Kell blood group system, which shift the protein 4.1 complex to proteins like glycophorin C in the RBC membrane.<xref ref-type="bibr" rid="article-142043.r29">[29]</xref><xref ref-type="bibr" rid="article-142043.r30">[30]</xref>&#x000a0;</p>
        <p>
<bold>Lab method for Kell blood group determination</bold>
</p>
        <p>Determining the Kell blood group involves various methodologies, each with advantages and limitations. These methods can be broadly categorized into serological and molecular techniques.<xref ref-type="bibr" rid="article-142043.r31">[31]</xref>&#x000a0;In serological methods, hemagglutination tests such as forward typing are commonly used to detect the presence of Kell antigens on RBCs by utilizing specific antibodies like anti-K. Agglutination indicates the presence of the K antigen, while a lack of agglutination suggests its absence. Although this method is rapid and straightforward, it may lack sensitivity for weakly expressed antigens, particularly in partial or weak Kell phenotypes.<xref ref-type="bibr" rid="article-142043.r32">[32]</xref> Reverse typing involves testing the serum for anti-K antibodies to confirm the results of forward typing, which is crucial for ensuring accurate blood typing before transfusions. This step helps identify any unexpected antibodies that could lead to transfusion reactions.<xref ref-type="bibr" rid="article-142043.r33">[33]</xref> Another technique, gel centrifugation, employs a gel medium to separate agglutinated from non-agglutinated cells, thereby improving sensitivity and specificity. This method is particularly beneficial in reducing false-negative results and is often used in blood banks for routine testing.<xref ref-type="bibr" rid="article-142043.r34">[34]</xref></p>
        <p>In molecular methods, polymerase chain reaction (PCR)-based techniques are highly sensitive and detect specific genotypes associated with Kell antigens. This approach is particularly useful in cases where serological methods may fail, such as in patients with autoimmune hemolytic anemia or those who have been recently transfused, as these conditions can obscure antigen expression.<xref ref-type="bibr" rid="article-142043.r35">[35]</xref> PCR with sequence-specific primers (PCR-SSP) enables the determination of specific alleles associated with Kell antigens; this is both cost-effective and reliable, making it suitable for routine testing in blood banks. This method can also identify rare phenotypes that may not be detected through serological means.<xref ref-type="bibr" rid="article-142043.r36">[36]</xref> PCR with restriction fragment length polymorphism (PCR-RFLP) analyzes variations in DNA sequences corresponding to different Kell antigens, providing detailed genetic information about blood group polymorphisms. This level of detail can be crucial for understanding compatibility in transfusions and organ transplants.<xref ref-type="bibr" rid="article-142043.r37">[37]</xref><xref ref-type="bibr" rid="article-142043.r38">[38]</xref> Microarray technology, which can simultaneously analyze multiple blood group antigens, including Kell, is highly efficient for large-scale screenings and provides comprehensive data on various blood group systems. This method allows for rapid screening of donors and patients alike, facilitating better matching processes.<xref ref-type="bibr" rid="article-142043.r39">[39]</xref></p>
      </sec>
      <sec id="article-142043.s2" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p><bold>Functional Role of Kell Blood Group System</bold>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>RBC adhesion: Kell antigens are involved in RBC adhesion with vascular endothelium and act by cleaving endothelin-3.<xref ref-type="bibr" rid="article-142043.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>RBC cell signaling: Results from recent studies show that recipient type-1 interferon production regulates RBC alloimmunization with Kel1 antigen.<xref ref-type="bibr" rid="article-142043.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Red cell structural integrity: All Kell blood group antigens and the Cartwright (Yta) antigen are completely denatured on treatment with DTT in the same concentration range, showing possible relation related to the disulfide bond integrity of the RBC membrane.<xref ref-type="bibr" rid="article-142043.r41">[41]</xref></p>
          </list-item>
          <list-item>
            <p>Erythroid lineage suppression: The presence of Kell antigens on erythroid precursors has been proven by suppression with anti-Kell antibodies on RBC production. These antibodies inhibit the colony-forming units and cause severe fetal anemia in the case of HDFN.<xref ref-type="bibr" rid="article-142043.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>Role in platelet inhibition: Besides the erythroid series, Kell antigens are also on the megakaryocytic precursors. In the case of anti-Kell antibody formation, these antibodies inhibit the precursor cells and lead to thrombocytopenia.<xref ref-type="bibr" rid="article-142043.r43">[43]</xref><xref ref-type="bibr" rid="article-142043.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Association with gram-negative bacterial infection: IgM-type Kell antibodies have been identified in patients afflicted with <italic toggle="yes">E coli</italic> 0125:B15 enterocolitis.<xref ref-type="bibr" rid="article-142043.r14">[14]</xref><xref ref-type="bibr" rid="article-142043.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p>Association with mycobacterium: IgM-type naturally occurring anti-Kell antibodies have been identified in a previously non-sensitized individual suffering from pulmonary tuberculosis.<xref ref-type="bibr" rid="article-142043.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Kell Blood Group System and Disease Association</bold>
</p>
        <p>McLeod syndrome is an X-linked recessive disorder due to the absence of Kx protein, resulting in the loss of Kell antigen functions in red blood cells. Hematologically, it is characterized by irregular protrusions or acanthocytes on the red cell membrane, leading to decreased survival of RBCs and presenting with chronic, compensated hemolytic anemia. Patients with this condition also have several neuromuscular abnormalities termed McLeod neuro-acanthocytosis syndrome.</p>
        <p>The neurological manifestation&#x000a0;comprises movement disorders such as choreiform movements or facial tics and neuropsychiatric symptoms involving depression, anxiety, psychosis, obsessive-compulsive features, and cognitive dysfunction. These patients develop slow progressive muscular dystrophy, which starts in middle age and worsens with time. Cardiac symptoms include cardiomegaly, atrial fibrillation, and arrhythmia. Additionally, patients may also&#x000a0;have seizures, dysarthria, dysphagia, and areflexia. There are increased creatinine kinase and carbonic anhydrase III levels in biochemical parameters.<xref ref-type="bibr" rid="article-142043.r46">[46]</xref></p>
        <p>Chronic granulomatous disease and McLeod syndrome: Chronic granulomatous disease (CGD) is an X-linked disorder caused by mutations in&#x000a0;<italic toggle="yes">CYBB</italic>, which encodes the nicotinamide adenine dinucleotide phosphate oxidase complex crucial for phagocytes to kill ingested pathogens. CGD is occasionally associated with McLeod syndrome due to contiguous gene deletion on the X chromosome.<xref ref-type="bibr" rid="article-142043.r47">[47]</xref></p>
        <p>Hematological malignancies: In hematological malignancies, anti-Kell antibodies may be warm-type autoantibodies or naturally occurring alloantibodies against the Kell antigen.<xref ref-type="bibr" rid="article-142043.r48">[48]</xref><xref ref-type="bibr" rid="article-142043.r49">[49]</xref></p>
        <p>HDFN and neonatal jaundice: Antibodies to the Kell system can cause severe HDFN and fetal death. These IgG antibodies destroy mature fetal RBCs and the erythroid precursor cells by inhibiting erythropoiesis. In the Kell blood group-related HDFN, the degree of anemia and bilirubin levels are unrelated to the severity of the disease.<xref ref-type="bibr" rid="article-142043.r50">[50]</xref><xref ref-type="bibr" rid="article-142043.r51">[51]</xref>&#x000a0;A noninvasive prenatal test involving cell-free fetal DNA can be used for fetal antigen genotyping to diagnose HDFN.<xref ref-type="bibr" rid="article-142043.r52">[52]</xref></p>
        <p>Transfusion: The Kell antigens are the most immunogenic, third only after ABO and Rhesus blood group systems. Antibodies to the Kell system are predominantly IgG and clinically significant. They are known to cause acute and delayed hemolytic transfusion reactions, which can be severe as well.<xref ref-type="bibr" rid="article-142043.r53">[53]</xref></p>
      </sec>
      <sec id="article-142043.s3" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Understanding the Kell blood group system is crucial for improving patient outcomes and equally important for clinical and laboratory clinicians. Continued research into the <italic toggle="yes">KEL</italic> gene and its associated protein is necessary across different diseases and to examine transfusion outcomes and clinical consequences. The nursing team must verify the availability of a Kell antigen-negative blood unit and the other mandatory pretransfusion checks when planning transfusions for patients with Kell antibodies.</p>
      </sec>
      <sec id="article-142043.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=142043&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=142043">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/142043/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=142043">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-142043.s5">
        <title>References</title>
        <ref id="article-142043.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lomas-Francis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vege</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Velliquette</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Fuchisawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uchikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Debnath</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.</article-title>
            <source>Transfusion</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>11 Suppl 2</issue>
            <fpage>2887</fpage>
            <page-range>2887-91</page-range>
            <pub-id pub-id-type="pmid">23968329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grandi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>ABO and Rh blood groups and risk of infection: systematic review and meta-analysis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2023</year>
            <month>Nov</month>
            <day>14</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>797</fpage>
            <pub-id pub-id-type="pmid">37964217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Danek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>McLeod syndrome: a neurohaematological disorder.</article-title>
            <source>Vox Sang</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-21</page-range>
            <pub-id pub-id-type="pmid">17683354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniels</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The molecular genetics of blood group polymorphism.</article-title>
            <source>Transpl Immunol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>3-4</issue>
            <fpage>143</fpage>
            <page-range>143-53</page-range>
            <pub-id pub-id-type="pmid">15982556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Twu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.</article-title>
            <source>J Biol Chem</source>
            <year>2001</year>
            <month>Mar</month>
            <day>30</day>
            <volume>276</volume>
            <issue>13</issue>
            <fpage>10247</fpage>
            <page-range>10247-52</page-range>
            <pub-id pub-id-type="pmid">11134029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Narla</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Blood group antigens in health and disease.</article-title>
            <source>Curr Opin Hematol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-40</page-range>
            <pub-id pub-id-type="pmid">15725904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Functional and structural aspects of the Kell blood group system.</article-title>
            <source>Transfus Med Rev</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-103</page-range>
            <pub-id pub-id-type="pmid">10782495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bland</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Pinney</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Isaac</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships.</article-title>
            <source>BMC Evol Biol</source>
            <year>2008</year>
            <month>Jan</month>
            <day>23</day>
            <volume>8</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">18215274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Debnath</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.</article-title>
            <source>Blood</source>
            <year>2003</year>
            <month>Oct</month>
            <day>15</day>
            <volume>102</volume>
            <issue>8</issue>
            <fpage>3028</fpage>
            <page-range>3028-34</page-range>
            <pub-id pub-id-type="pmid">12842980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Veldhuisen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ligthart</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Haer-Wigman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jongerius</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boujnan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ait Soussan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>van der Schoot</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>de Haas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.</article-title>
            <source>Transfusion</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>413</fpage>
            <page-range>413-21</page-range>
            <pub-id pub-id-type="pmid">25156717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Redman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Kell blood group system.</article-title>
            <source>Transfus Clin Biol</source>
            <year>1995</year>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>243</fpage>
            <page-range>243-9</page-range>
            <pub-id pub-id-type="pmid">8542022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Berer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Geissler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells.</article-title>
            <source>Br J Haematol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>110</volume>
            <issue>2</issue>
            <fpage>409</fpage>
            <page-range>409-11</page-range>
            <pub-id pub-id-type="pmid">10971399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Expression of Kell blood group protein in nonerythroid tissues.</article-title>
            <source>Blood</source>
            <year>2000</year>
            <month>Jul</month>
            <day>01</day>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>340</fpage>
            <page-range>340-6</page-range>
            <pub-id pub-id-type="pmid">10891471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsh</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thayer</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Deere</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Freed</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Schmelter</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Naturally occurring anti-Kell stimulated by E. coli enterocolitis in a 20-day-old child.</article-title>
            <source>Transfusion</source>
            <year>1978</year>
            <season>Mar-Apr</season>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-54</page-range>
            <pub-id pub-id-type="pmid">347643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Molthan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Strohm</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Hemolytic transfusion reaction due to anti-Kell undetectable in low-ionic-strength solutions.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1981</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>629</fpage>
            <page-range>629-31</page-range>
            <pub-id pub-id-type="pmid">7223723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ewing</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salvador</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.</article-title>
            <source>Immunohematology</source>
            <year>2007</year>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">18004938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thapliyal</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Blood group gene frequency in a selected north Indian population.</article-title>
            <source>Indian J Med Res</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>106</volume>
            <fpage>242</fpage>
            <page-range>242-6</page-range>
            <pub-id pub-id-type="pmid">9378531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thakral</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Saluja</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors.</article-title>
            <source>Transfus Apher Sci</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">20558108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin-Chu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Broadberry</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>The distribution of blood group antigens and alloantibodies among Chinese in Taiwan.</article-title>
            <source>Transfusion</source>
            <year>1988</year>
            <season>Jul-Aug</season>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>350</fpage>
            <page-range>350-2</page-range>
            <pub-id pub-id-type="pmid">3133846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdelaal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Anyaegbu</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>al Sobhi</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>al Baz</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Hodan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Blood group phenotype distribution in Saudi Arabs.</article-title>
            <source>Afr J Med Med Sci</source>
            <year>1999</year>
            <season>Sep-Dec</season>
            <volume>28</volume>
            <issue>3-4</issue>
            <fpage>133</fpage>
            <page-range>133-5</page-range>
            <pub-id pub-id-type="pmid">11205816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CHOWN</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>LEWIS</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>KAITA</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A new Kell blood-group phenotype.</article-title>
            <source>Nature</source>
            <year>1957</year>
            <month>Oct</month>
            <day>05</day>
            <volume>180</volume>
            <issue>4588</issue>
            <fpage>711</fpage>
            <pub-id pub-id-type="pmid">13477267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and molecular basis of null blood group phenotypes in the Korean population: Analysis using a public database.</article-title>
            <source>Transfusion</source>
            <year>2024</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-23</page-range>
            <pub-id pub-id-type="pmid">38031501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Fatal hemolytic transfusion reaction due to anti-Ku in a Knull patient.</article-title>
            <source>Immunohematology</source>
            <year>2003</year>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-21</page-range>
            <pub-id pub-id-type="pmid">15373542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pham</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Gien</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bensaad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Babinet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dubeaux</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rouger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Pennec</surname>
                <given-names>PY</given-names>
              </name>
            </person-group>
            <article-title>Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution.</article-title>
            <source>Transfusion</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>844</fpage>
            <page-range>844-8</page-range>
            <pub-id pub-id-type="pmid">21910740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype.</article-title>
            <source>Transfusion</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>1121</fpage>
            <page-range>1121-5</page-range>
            <pub-id pub-id-type="pmid">12869119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ALLEN</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>KRABBE</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>CORCORAN</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>A new phenotype (McLeod) in the Kell blood-group system.</article-title>
            <source>Vox Sang</source>
            <year>1961</year>
            <month>Sep</month>
            <volume>6</volume>
            <fpage>555</fpage>
            <page-range>555-60</page-range>
            <pub-id pub-id-type="pmid">13860532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertelson</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Pogo</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Chaudhuri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Symmans</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kunkel</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Localization of the McLeod locus (XK) within Xp21 by deletion analysis.</article-title>
            <source>Am J Hum Genet</source>
            <year>1988</year>
            <month>May</month>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>703</fpage>
            <page-range>703-11</page-range>
            <pub-id pub-id-type="pmid">3358422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsh</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Schnipper</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>An individual with McLeod syndrome and the Kell blood group antigen K(K1).</article-title>
            <source>Transfusion</source>
            <year>1983</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>336</fpage>
            <page-range>336-8</page-range>
            <pub-id pub-id-type="pmid">6879675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salomao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hartwig</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chasis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2008</year>
            <month>Jun</month>
            <day>10</day>
            <volume>105</volume>
            <issue>23</issue>
            <fpage>8026</fpage>
            <page-range>8026-31</page-range>
            <pub-id pub-id-type="pmid">18524950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaskiewicz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peyrard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kaczmarek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zerka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jodlowska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Czerwinski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The Gerbich blood group system: old knowledge, new importance.</article-title>
            <source>Transfus Med Rev</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-116</page-range>
            <pub-id pub-id-type="pmid">29540278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Detection of Kell blood groups: molecular methods in the diagnostic laboratory.</article-title>
            <source>Blood Rev</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-15</page-range>
            <pub-id pub-id-type="pmid">9218102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Blood Group Testing.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2022</year>
            <volume>9</volume>
            <fpage>827619</fpage>
            <pub-id pub-id-type="pmid">35223922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mujahid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dickert</surname>
                <given-names>FL</given-names>
              </name>
            </person-group>
            <article-title>Blood Group Typing: From Classical Strategies to the Application of Synthetic Antibodies Generated by Molecular Imprinting.</article-title>
            <source>Sensors (Basel)</source>
            <year>2015</year>
            <month>Dec</month>
            <day>31</day>
            <volume>16</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">26729127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapierre</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rigal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Josef</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Greber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Drot</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The gel test: a new way to detect red cell antigen-antibody reactions.</article-title>
            <source>Transfusion</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-13</page-range>
            <pub-id pub-id-type="pmid">2305438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorakshakar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gogri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Evolution of technology for molecular genotyping in blood group systems.</article-title>
            <source>Indian J Med Res</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>146</volume>
            <issue>3</issue>
            <fpage>305</fpage>
            <page-range>305-315</page-range>
            <pub-id pub-id-type="pmid">29355136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quirino</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Colli</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Macedo</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Sell</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Visentainer</surname>
                <given-names>JEL</given-names>
              </name>
            </person-group>
            <article-title>Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping.</article-title>
            <source>Hematol Transfus Cell Ther</source>
            <year>2019</year>
            <season>Jan-Mar</season>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-49</page-range>
            <pub-id pub-id-type="pmid">30793104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sell</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Visentainer</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Blood grouping based on PCR methods and agarose gel electrophoresis.</article-title>
            <source>Methods Mol Biol</source>
            <year>2015</year>
            <volume>1310</volume>
            <fpage>37</fpage>
            <page-range>37-49</page-range>
            <pub-id pub-id-type="pmid">26024624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnoni</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Muniz</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>de Paula</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Person</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Gazito</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baleotti</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barreto</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Castilho</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Latini</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>An easy and efficient strategy for KEL genotyping in a multiethnic population.</article-title>
            <source>Rev Bras Hematol Hemoter</source>
            <year>2013</year>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-102</page-range>
            <pub-id pub-id-type="pmid">23741186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paris</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rigal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barlet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Verdier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coudurier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bailly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Br&#x000e8;s</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Flexible automated platform for blood group genotyping on DNA microarrays.</article-title>
            <source>J Mol Diagn</source>
            <year>2014</year>
            <month>May</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>335</fpage>
            <page-range>335-42</page-range>
            <pub-id pub-id-type="pmid">24726279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gibb</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Escamilla-Rivera</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santhanakrishnan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eisenbarth</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Hendrickson</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.</article-title>
            <source>Transfusion</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>10</issue>
            <fpage>3243</fpage>
            <page-range>3243-3252</page-range>
            <pub-id pub-id-type="pmid">31403208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Branch</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Muensch</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Sy Siok Hian</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Petz</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity.</article-title>
            <source>Br J Haematol</source>
            <year>1983</year>
            <month>Aug</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>573</fpage>
            <page-range>573-8</page-range>
            <pub-id pub-id-type="pmid">6871108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaughan</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warwick</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Letsky</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Mar</month>
            <day>19</day>
            <volume>338</volume>
            <issue>12</issue>
            <fpage>798</fpage>
            <page-range>798-803</page-range>
            <pub-id pub-id-type="pmid">9504940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bernaschek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Geissler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of megakaryopoiesis by Kell-related antibodies.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Jul</month>
            <day>06</day>
            <volume>343</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <pub-id pub-id-type="pmid">10896554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lanzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Geissler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Kell expression on myeloid progenitor cells.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>479</fpage>
            <page-range>479-85</page-range>
            <pub-id pub-id-type="pmid">12002749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savalonis</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kalish</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Aloisi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Kell blood group activity of gram-negative bacteria.</article-title>
            <source>Transfusion</source>
            <year>1988</year>
            <season>May-Jun</season>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-32</page-range>
            <pub-id pub-id-type="pmid">3368935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peikert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Danek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>VPS13 Forum Proceedings: XK, XK-Related and VPS13 Proteins in Membrane Lipid Dynamics.</article-title>
            <source>Contact (Thousand Oaks)</source>
            <year>2023</year>
            <season>Jan-Dec</season>
            <volume>6</volume>
            <fpage>25152564231156994</fpage>
            <pub-id pub-id-type="pmid">37366410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2005</year>
            <month>Apr</month>
            <day>12</day>
            <volume>102</volume>
            <issue>15</issue>
            <fpage>5552</fpage>
            <page-range>5552-7</page-range>
            <pub-id pub-id-type="pmid">15805191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mangwana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gangwar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Anti Kp<sup>a</sup> alloantibody: Development of a rare alloantibody in a non-Hodgkin's lymphoma patient of Indian origin.</article-title>
            <source>Asian J Transfus Sci</source>
            <year>2018</year>
            <season>Jan-Jun</season>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-84</page-range>
            <pub-id pub-id-type="pmid">29563682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okubo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>An example of naturally occurring anti-Kell (K1) in a Japanese male.</article-title>
            <source>Vox Sang</source>
            <year>1978</year>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-6</page-range>
            <pub-id pub-id-type="pmid">695444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Jonge</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Milani</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Krijnen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>van Krimpen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ponjee</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Haemolytic disease of the newborn due to anti-K antibodies.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">8789754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Harman</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Erythroblastosis fetalis produced by anti-k.</article-title>
            <source>Vox Sang</source>
            <year>1989</year>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>187</fpage>
            <page-range>187-9</page-range>
            <pub-id pub-id-type="pmid">2728396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cro'</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lapucci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vicari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Salsi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Farina</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.</article-title>
            <source>Am J Reprod Immunol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>76</volume>
            <issue>6</issue>
            <fpage>499</fpage>
            <page-range>499-503</page-range>
            <pub-id pub-id-type="pmid">27730708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142043.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PESCHEL</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McINTOSH</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>BROWN</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>MURDAUGH</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Acute tubular necrosis after transfusion reaction due to anti-Kell antibodies; report of a case and discussion of management.</article-title>
            <source>J Am Med Assoc</source>
            <year>1958</year>
            <month>Aug</month>
            <day>02</day>
            <volume>167</volume>
            <issue>14</issue>
            <fpage>1736</fpage>
            <page-range>1736-41</page-range>
            <pub-id pub-id-type="pmid">13563174</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
